These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11726192)

  • 1. Detection of ATP competitive protein kinase inhibition by Western blotting.
    Wang R; Thompson JE
    Anal Biochem; 2001 Dec; 299(1):110-2. PubMed ID: 11726192
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and characterization of 5'-p-fluorosulfonylbenzoyl-2' (or 3')-(biotinyl)adenosine as an activity-based probe for protein kinases.
    Ratcliffe SJ; Yi T; Khandekar SS
    J Biomol Screen; 2007 Feb; 12(1):126-32. PubMed ID: 17166825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to fluorylsulfonylbenzoyladenosine permit identification of protein kinases.
    Parker PJ
    FEBS Lett; 1993 Nov; 334(3):347-50. PubMed ID: 8243645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors.
    Laufer SA; Domeyer DM; Scior TR; Albrecht W; Hauser DR
    J Med Chem; 2005 Feb; 48(3):710-22. PubMed ID: 15689155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.
    Bogoyevitch MA; Fairlie DP
    Drug Discov Today; 2007 Aug; 12(15-16):622-33. PubMed ID: 17706543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase inhibitors: insights into drug design from structure.
    Noble ME; Endicott JA; Johnson LN
    Science; 2004 Mar; 303(5665):1800-5. PubMed ID: 15031492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases.
    Nam NH; Lee S; Ye G; Sun G; Parang K
    Bioorg Med Chem; 2004 Nov; 12(22):5753-66. PubMed ID: 15498652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of protein kinases by ATP-STD NMR spectroscopy.
    McCoy MA; Senior MM; Wyss DF
    J Am Chem Soc; 2005 Jun; 127(22):7978-9. PubMed ID: 15926798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-ATP competitive protein kinase inhibitors as anti-tumor therapeutics.
    Kirkland LO; McInnes C
    Biochem Pharmacol; 2009 May; 77(10):1561-71. PubMed ID: 19167366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP.
    Bao H; Kasten SA; Yan X; Roche TE
    Biochemistry; 2004 Oct; 43(42):13432-41. PubMed ID: 15491150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic mechanism and inhibitor characterization for c-jun-N-terminal kinase 3alpha1.
    Ember B; Kamenecka T; LoGrasso P
    Biochemistry; 2008 Mar; 47(10):3076-84. PubMed ID: 18269248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in the design of selective ATP-competitive kinase inhibitors].
    Deng XQ; Xiang ML; Jia R; Yang SY
    Yao Xue Xue Bao; 2007 Dec; 42(12):1232-6. PubMed ID: 18338633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence and structural analysis of kinase ATP pocket residues.
    Vulpetti A; Bosotti R
    Farmaco; 2004 Oct; 59(10):759-65. PubMed ID: 15474052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ATP site of protein kinases as target for drug development: from natural compounds to gleevec.
    Granot Y
    Isr Med Assoc J; 2002 Aug; 4(8):633-5. PubMed ID: 12183872
    [No Abstract]   [Full Text] [Related]  

  • 15. Mapping of the ATP-binding domain of human fructosamine 3-kinase-related protein by affinity labelling with 5'-[p-(fluorosulfonyl)benzoyl]adenosine.
    Payne LS; Brown PM; Middleditch M; Baker E; Cooper GJ; Loomes KM
    Biochem J; 2008 Dec; 416(2):281-8. PubMed ID: 18637789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface-plasmon-resonance-based biosensor with immobilized bisubstrate analog inhibitor for the determination of affinities of ATP- and protein-competitive ligands of cAMP-dependent protein kinase.
    Viht K; Schweinsberg S; Lust M; Vaasa A; Raidaru G; Lavogina D; Uri A; Herberg FW
    Anal Biochem; 2007 Mar; 362(2):268-77. PubMed ID: 17274940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and crystal structures of protein kinase B-selective inhibitors in complex with protein kinase A and mutants.
    Breitenlechner CB; Friebe WG; Brunet E; Werner G; Graul K; Thomas U; Künkele KP; Schäfer W; Gassel M; Bossemeyer D; Huber R; Engh RA; Masjost B
    J Med Chem; 2005 Jan; 48(1):163-70. PubMed ID: 15634010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kinase inhibitors].
    Hagiwara M; Usuki H
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1708-12. PubMed ID: 18051404
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides.
    Schirmer A; Kennedy J; Murli S; Reid R; Santi DV
    Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4234-9. PubMed ID: 16537514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of PI3-kinase isoforms: identification of residues enabling selective inhibition by small molecule ATP-competitive inhibitors.
    Zvelebil MJ; Waterfield MD; Shuttleworth SJ
    Arch Biochem Biophys; 2008 Sep; 477(2):404-10. PubMed ID: 18647592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.